201 related articles for article (PubMed ID: 7477441)
1. Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine cerebral microvessels.
Linville DG; Hamel E
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):179-86. PubMed ID: 7477441
[TBL] [Abstract][Full Text] [Related]
2. Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature.
Dauphin F; Hamel E
J Pharmacol Exp Ther; 1992 Feb; 260(2):660-7. PubMed ID: 1738116
[TBL] [Abstract][Full Text] [Related]
3. Characterization of muscarinic receptors of bovine coronary artery by functional and radioligand binding studies.
Brunner F; Kühberger E; Schloos J; Kukovetz WR
Eur J Pharmacol; 1991 Apr; 196(3):247-55. PubMed ID: 1893913
[TBL] [Abstract][Full Text] [Related]
4. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
5. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
6. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
Sharif NA; Williams GW; DeSantis LM
Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
[TBL] [Abstract][Full Text] [Related]
7. Characterization of muscarinic receptors in dog tracheal smooth muscle cells.
Yang CM
J Auton Pharmacol; 1991 Feb; 11(1):51-61. PubMed ID: 2030109
[TBL] [Abstract][Full Text] [Related]
8. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
9. Radioligand binding characteristics of the chicken cardiac muscarinic receptor.
Michel AD; Whiting RL
Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):279-84. PubMed ID: 2812039
[TBL] [Abstract][Full Text] [Related]
10. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
[TBL] [Abstract][Full Text] [Related]
12. Characterization of muscarinic receptor subtypes in pig airways: radioligand binding and northern blotting studies.
Haddad EB; Mak JC; Hislop A; Haworth SG; Barnes PJ
Am J Physiol; 1994 Jun; 266(6 Pt 1):L642-8. PubMed ID: 8023952
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
Cortés R; Probst A; Tobler HJ; Palacios JM
Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
[TBL] [Abstract][Full Text] [Related]
14. Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard.
Yoshida A; Seki M; Nasrin S; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Ehlert FJ; Yamada S
Urology; 2011 Sep; 78(3):721.e7-721.e12. PubMed ID: 21777958
[TBL] [Abstract][Full Text] [Related]
15. M1 and M3 muscarinic receptor subtypes in rat forebrain.
Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
[TBL] [Abstract][Full Text] [Related]
16. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
Smith TD; Annis SJ; Ehlert FJ; Leslie FM
J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
[TBL] [Abstract][Full Text] [Related]
17. Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract.
Abraham G; Kottke C; Ammer H; Dhein S; Ungemach FR
Vet Res Commun; 2007 Feb; 31(2):207-26. PubMed ID: 17180451
[TBL] [Abstract][Full Text] [Related]
18. On the interaction of gallamine with muscarinic receptor subtypes.
Michel AD; Delmendo RE; Lopez M; Whiting RL
Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
[TBL] [Abstract][Full Text] [Related]
19. Influence of monovalent cations on the binding of a charged and an uncharged ('carbo'-)muscarinic antagonist to muscarinic receptors.
Hou X; Wehrle J; Menge W; Ciccarelli E; Wess J; Mutschler E; Lambrecht G; Timmerman H; Waelbroeck M
Br J Pharmacol; 1996 Mar; 117(5):955-61. PubMed ID: 8851517
[TBL] [Abstract][Full Text] [Related]
20. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
